These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
205 related articles for article (PubMed ID: 31356090)
1. Enhancing Nab-Paclitaxel Delivery Using Microbubble-Assisted Ultrasound in a Pancreatic Cancer Model. Bressand D; Novell A; Girault A; Raoul W; Fromont-Hankard G; Escoffre JM; Lecomte T; Bouakaz A Mol Pharm; 2019 Sep; 16(9):3814-3822. PubMed ID: 31356090 [TBL] [Abstract][Full Text] [Related]
2. Sonoporation with Acoustic Cluster Therapy (ACT®) induces transient tumour volume reduction in a subcutaneous xenograft model of pancreatic ductal adenocarcinoma. Kotopoulis S; Stigen E; Popa M; Safont MM; Healey A; Kvåle S; Sontum P; Gjertsen BT; Gilja OH; McCormack E J Control Release; 2017 Jan; 245():70-80. PubMed ID: 27871988 [TBL] [Abstract][Full Text] [Related]
3. Synthesis of a gemcitabine-modified phospholipid and its subsequent incorporation into a single microbubble formulation loaded with paclitaxel for the treatment of pancreatic cancer using ultrasound-targeted microbubble destruction. Logan KA; Nesbitt H; Callan B; Gao J; McKaig T; Taylor M; Love M; McHale AP; Callan JF Eur J Pharm Biopharm; 2021 Aug; 165():374-382. PubMed ID: 34038797 [TBL] [Abstract][Full Text] [Related]
4. Augmentation of response to nab-paclitaxel by inhibition of insulin-like growth factor (IGF) signaling in preclinical pancreatic cancer models. Awasthi N; Scire E; Monahan S; Grojean M; Zhang E; Schwarz MA; Schwarz RE Oncotarget; 2016 Jul; 7(30):46988-47001. PubMed ID: 27127884 [TBL] [Abstract][Full Text] [Related]
5. Albumin-bound nanoparticle (nab) paclitaxel exhibits enhanced paclitaxel tissue distribution and tumor penetration. Chen N; Brachmann C; Liu X; Pierce DW; Dey J; Kerwin WS; Li Y; Zhou S; Hou S; Carleton M; Klinghoffer RA; Palmisano M; Chopra R Cancer Chemother Pharmacol; 2015 Oct; 76(4):699-712. PubMed ID: 26231955 [TBL] [Abstract][Full Text] [Related]
6. Therapeutic efficacy of anti-MMP9 antibody in combination with nab-paclitaxel-based chemotherapy in pre-clinical models of pancreatic cancer. Awasthi N; Mikels-Vigdal AJ; Stefanutti E; Schwarz MA; Monahan S; Smith V; Schwarz RE J Cell Mol Med; 2019 Jun; 23(6):3878-3887. PubMed ID: 30941918 [TBL] [Abstract][Full Text] [Related]
7. Synergistic anti-tumor effect of paclitaxel and miR-34a combined with ultrasound microbubbles on cervical cancer in vivo and in vitro. Yu J; Zhao Y; Liu C; Hu B; Zhao M; Ma Y; Jiang J Clin Transl Oncol; 2020 Jan; 22(1):60-69. PubMed ID: 31093891 [TBL] [Abstract][Full Text] [Related]
8. S-1 plus nab-paclitaxel is a promising regimen for pancreatic cancer in a preclinical model. Suenaga M; Yamada S; Fujii T; Tanaka C; Kanda M; Nakayama G; Sugimoto H; Koike M; Fujiwara M; Kodera Y J Surg Oncol; 2016 Mar; 113(4):413-9. PubMed ID: 27100026 [TBL] [Abstract][Full Text] [Related]
9. Paclitaxel-liposome-microbubble complexes as ultrasound-triggered therapeutic drug delivery carriers. Yan F; Li L; Deng Z; Jin Q; Chen J; Yang W; Yeh CK; Wu J; Shandas R; Liu X; Zheng H J Control Release; 2013 Mar; 166(3):246-55. PubMed ID: 23306023 [TBL] [Abstract][Full Text] [Related]
10. SPARC independent drug delivery and antitumour effects of nab-paclitaxel in genetically engineered mice. Neesse A; Frese KK; Chan DS; Bapiro TE; Howat WJ; Richards FM; Ellenrieder V; Jodrell DI; Tuveson DA Gut; 2014 Jun; 63(6):974-83. PubMed ID: 24067278 [TBL] [Abstract][Full Text] [Related]
11. Porphyrin-grafted Lipid Microbubbles for the Enhanced Efficacy of Photodynamic Therapy in Prostate Cancer through Ultrasound-controlled You Y; Liang X; Yin T; Chen M; Qiu C; Gao C; Wang X; Mao Y; Qu E; Dai Z; Zheng R Theranostics; 2018; 8(6):1665-1677. PubMed ID: 29556348 [TBL] [Abstract][Full Text] [Related]
12. Macropinocytosis of Nab-paclitaxel Drives Macrophage Activation in Pancreatic Cancer. Cullis J; Siolas D; Avanzi A; Barui S; Maitra A; Bar-Sagi D Cancer Immunol Res; 2017 Mar; 5(3):182-190. PubMed ID: 28108630 [TBL] [Abstract][Full Text] [Related]
13. Ultrasound-Mediated Microbubble Destruction (UMMD) Facilitates the Delivery of CA19-9 Targeted and Paclitaxel Loaded mPEG-PLGA-PLL Nanoparticles in Pancreatic Cancer. Xing L; Shi Q; Zheng K; Shen M; Ma J; Li F; Liu Y; Lin L; Tu W; Duan Y; Du L Theranostics; 2016; 6(10):1573-87. PubMed ID: 27446491 [TBL] [Abstract][Full Text] [Related]
14. Therapeutic Ultrasound Contrast Agents for the Enhancement of Tumor Diagnosis and Tumor Therapy. Moon H; Yoon C; Lee TW; Ha KS; Chang JH; Song TK; Kim K; Kim H J Biomed Nanotechnol; 2015 Jul; 11(7):1183-92. PubMed ID: 26307841 [TBL] [Abstract][Full Text] [Related]
15. Radiation-guided drug delivery to mouse models of lung cancer. Hariri G; Yan H; Wang H; Han Z; Hallahan DE Clin Cancer Res; 2010 Oct; 16(20):4968-77. PubMed ID: 20802016 [TBL] [Abstract][Full Text] [Related]
16. Ultrasound contrast-enhanced imaging and in vitro antitumor effect of paclitaxel-poly(lactic-co-glycolic acid)-monomethoxypoly (ethylene glycol) nanocapsules with ultrasound-targeted microbubble destruction. Ma J; Xing LX; Shen M; Li F; Zhu MJ; Jin LF; Li Z; Gao F; Su Y; Duan YR; Du LF Mol Med Rep; 2015 Apr; 11(4):2413-20. PubMed ID: 25500683 [TBL] [Abstract][Full Text] [Related]
17. Metabolic Adaptation during nab-Paclitaxel Resistance in Pancreatic Cancer Cell Lines. Braun LM; Lagies S; Guenzle J; Fichtner-Feigl S; Wittel UA; Kammerer B Cells; 2020 May; 9(5):. PubMed ID: 32438599 [TBL] [Abstract][Full Text] [Related]
18. Biodegradable double-targeted PTX-mPEG-PLGA nanoparticles for ultrasound contrast enhanced imaging and antitumor therapy in vitro. Ma J; Shen M; Xu CS; Sun Y; Duan YR; Du LF Oncotarget; 2016 Nov; 7(48):80008-80018. PubMed ID: 27835907 [TBL] [Abstract][Full Text] [Related]
19. Enhanced delivery of paclitaxel liposomes using focused ultrasound with microbubbles for treating nude mice bearing intracranial glioblastoma xenografts. Shen Y; Pi Z; Yan F; Yeh CK; Zeng X; Diao X; Hu Y; Chen S; Chen X; Zheng H Int J Nanomedicine; 2017; 12():5613-5629. PubMed ID: 28848341 [TBL] [Abstract][Full Text] [Related]
20. The winning formulation: the development of paclitaxel in pancreatic cancer. Ma WW; Hidalgo M Clin Cancer Res; 2013 Oct; 19(20):5572-9. PubMed ID: 23918602 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]